A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain

计划入组 25 人 · 首次发布于 2026 年 2 月 6 日

Intracept Intraosseous Basivertebral Nerve Ablation

计划入组 150 人 · 首次发布于 2022 年 12 月 21 日

Basivertebral Nerve Ablation With the Intracept Procedure

计划入组 70 人 · 首次发布于 2023 年 1 月 20 日

BVN-008

Nerve Growth Factor

Rx

mouse nerve growth factor

ASSOCIATION OF EXTREMITY NERVE SURGEONS

United States

Axogen Corporation

United States

Ryder System

United States

Stryker Receives FDA Clearance for OptaBlate BVN System to Treat Chronic Lower Back Pain

Stryker Receives FDA Clearance for OptaBlate BVN System to Treat Chronic Low Back Pain

Medtronic Expands Pain Portfolio with FDA-Cleared ViaVerte Basivertebral Nerve Ablation System